Proliferation and remodeling of the peritubular microcirculation after nephron reduction: Association with the progression of renal lesions

American Journal of Pathology

Volumn 159, Issue 2, 2001, Pages 547-560

  Pillebout, Evangéline ^a   Burtin, Martine ^a   Yuan, Hai T ^b   Briand, Pascale ^c   Woolf, Adrian S ^b   Friedlander, Gérard ^a   Terzi, Fabiola ^a  

^a INSERM   (France)

^b INSTITUT COCHIN   (France)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CYCLINE; DEXTRAN; FLUORESCEIN ISOTHIOCYANATE; TYROSINE KINASE RECEPTOR; TYROSINE KINASE RECEPTOR TIE 2; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CELL REGENERATION; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; FEMALE; FLUORESCENCE ANGIOGRAPHY; GLOMERULUS CAPILLARY; HEREDITY; KIDNEY TUBULE; MICROCIRCULATION; MOUSE; NEPHRON; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

EID: 0034884995     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)61726-9     Document Type: Article

References (48)

1. Progression of renal disease and renal hypertrophy
2. Morphometry of the renal corpuscle during normal postnatal growth and compensatory hypertrophy. A light microscope study
3. Subtotal but not unilateral nephrectomy induces hyperplasia and protooncogene expression
4. Mechanisms involved in the pathogenesis of tubulointerstitial fibrosis in 5/6-nephrectomized rats
5. Sodium restriction decreases AP-1 activation after nephron reduction in the rat: Role in the progression of renal lesions
6. Angiotensin II receptor antagonist ameliorates renal tubulointerstitial fibrosis caused by unilateral ureteral obstruction
7. Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor
8. Therapeutic intervention in glomerulonephritis by oligonucleotides
9. Targeted expression of a dominant-negative EGF-R in the kidney reduces tubulo-interstitial lesions after renal injury
10. Glomerular damage after uninephrectomy in young rats. I. Hypertrophy and distortion of capillary architecture
11. Apoptosis in glomerular endothelial cells during the development of glomerulosclerosis in the remnant-kidney model
12. Peritubular capillary injury during the progression of experimental glomerulonephritis in rats
13. Number of interstitial capillary cross-sections assessed by monoclonal antibodies: Relation to interstitial damage
14. Significance of postglomerular capillaries in the pathogenesis of chronic renal failure
15. Expression of platelet-derived endothelial cell growth factor and its potential role in up-regulation of angiogenesis in scarred kidneys secondary to urinary tract diseases
16. Mechanisms of angiogenesis and arteriogenesis
17. Role of vascular endothelial growth factor in the regulation of angiogenesis
18. Vascular endothelial growth factor is an essential molecule for mouse kidney development: Glomerulogenesis and nephrogenesis
19. Expression of vascular endothelial growth factor and its receptors in human renal ontogenesis and in adult kidney
20. Expression of angiopoietin-1, anglopoletin-2, and the Tie-2 receptor tyrosine kinase during mouse kidney maturation
21. Reduction of renal mass is lethal in mice lacking vimentin. Role of endothelin-nitric oxide imbalance
22. Renal effect of anti-hypertensive drugs depends on sodium diet in the excision remnant kidney model
23. Subtotal nephrectomy alters tubular function: Effect of phosphorus restriction
24. Interstitial pH and pO2 gradients in solid tumors in vivo: High-resolution measurements reveal a lack of correlation
25. Angiogenesis in mice with chronic airway inflammation: Strain-dependent differences
26. Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas
27. Angiogenesis in autosomal dominant polycystic kidney disease
28. Pathophysiology of tumor angiogenesis and its relevance in renal cell cancer
29. Is there a common mechanism for the progression of different types of renal diseases other than proteinuria? Towards the unifying theme of chronic hypoxia
30. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
31. Antitumour effect of a synthetic analogue of fumagillin on murine renal carcinoma
32. Endostatin: Yeast production, mutants, and antitumor effect in renal cell carcinoma
33. Induction of angiogenesis during the transition from hyperplasia to neoplasia
34. Hepatocellular hypoxia-induced vascular endothelial growth factor expression and angiogenesis in experimental biliary cirrhosis
35. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders
36. Localization of endothelial proliferation and microvascular expansion in active plaque psoriasis
37. Angiogenesis: Potentials for pharmacologic intervention in the treatment of cancer, cardiovascular diseases, and chronic inflammation
38. Receptors of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) in fetal and adult human kidney: Localization and [125I]VEGF binding sites
39. Expression of vascular permeability factor (VPF/VEGF) is altered in many glomerular diseases
40. Expression of vascular endothelial growth factor in renal vascular disease and renal allografts
41. A potential role for angiotensin II-induced vascular endothelial growth factor expression in the pathogenesis of diabetic nephropathy?
42. VEGF(165) mediates glomerular endothelial repair
43. Redistribution of cytoplasmic VEGF to the basolateral aspect of renal tubular cells in ischemia-reperfusion injury
44. Early molecular mechanisms in the progression of renal failure: Role of growth factors and protooncogenes
45. The course of the remnant kidney model in mice
46. The lack of a functional p21(WAF1/CIP1) gene ameliorates progression to chronic renal failure
47. Nature and severity of the glomerular response to nephron reduction is strain-dependent in mice
48. Effect of tissue factor deficiency on mouse and tumor development